degree at McGill University. Rami Hannoush is a co-founder, President and interim CEO of EpiBiologics. Supplementary Figure 3 S6Taught/moderated by Ryan Watts, founder/CEO of Denali Therapeutics, and Rami Hannoush, former senior scientist at Genentech and now a partner at Mubadala, who bring in former / current colleagues to introduce each of the major functions (e. Auron was founded by a world class team of physicians and scientists with proven expertise in bringing effective differentiation therapies to patients. A. Rami N. and Jim Wells to the portfolio. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. D. D. Unparalleled access to new data & case studies from globally recognized speakers across the entire landscape of oligonucleotides, peptides, mRNA, genome. Rami Hannoush, Ph. 1016/j. D. Rami Hannoush, Ph. . “We would like to thank Rami Hannoush for his leadership as co-founder and interim CEO and look forward to an exciting next stage of growth for EpiBiologics under Ann’s leadership. Thrilled to share this work from my former group at Genentech, reporting on a new class of peptide agonists that modulate. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1w EditedRami Hannoush; Found 5 results for your query: Rami Hannoush in the United States of America. D. D. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…We would like to show you a description here but the site won’t allow us. ’s Post Rami Hannoush, Ph. Xinxin Gao and Rami Hannoush designed and analyzed experiments and wrote the paper. Rami N. Baran . Rami Hannoush, Ph. Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Back. Rami Hannoush, Ph. For info and…Biomarker sits down with Rami Hannoush, General Partner at Mubadala Capital Ventures. ’s Post Rami Hannoush, Ph. Rami N Hannoush is part of Stanford Profiles, official site for faculty, postdocs, students and staff information (Expertise, Bio, Research, Publications, and more). Lawyers - Get Listed Now! Get a free. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami N. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. Rami Hannoush is a co-founder, President and interim CEO of EpiBiologics. He most recently served as a general partner at Mubadala Capital, building the firm's healthcare platform in the. and Jim Wells to the portfolio. Rami Hannoush, Ph. … | 79 comments on LinkedInCongratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. About this. Contact Email [email protected] Abstract Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. 2017. D. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. The company has headquarters in San Mateo, CA. Rami Hannoush, Ph. A fascinating approach to degrade membrane proteins/receptors. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. PubMed Abstract: Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5). … | 77 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami most recently served as a general partner at Mubadala Capital, building the firm’s healthcare platform in the U. Rami Hannoush, Dr. The author has an hindex of 28, co-authored 68 publications receiving 2989 citations. ’s Post Rami Hannoush, Ph. Beitrag von Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Background. Back. Citizen and Immigration Services 2019 Outstanding Americans by. Yen, founder and CEO. … | 80 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Healthcare VC | Life sciences company creation | Former R&D leader, GenentechComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. He is co-founder of several biotech companies: EMcision Ltd, OmniCyte Ltd, MiNA Therapeutics Ltd, Apterna Ltd, Medeva Plc and Bioenvision Ltd. Fatty acylation of proteins is a versatile co-translational or post-translational modification that plays a key role in human. The site facilitates research and collaboration in academic endeavors. 1073/pnas. Genentech Inc. Apply now and find other jobs on WIZBIIRami Hannoush, Ph. Recent News and Activity. Symposium Sponsors. Rami. J Pharm Sci 2022 07 10;111(7):1896-1910. Lotte Simonsen, Novo Nordisk. D. Here’s everything you need to know about […]Correspondence to Rami N Hannoush. 我于2006年加入了Genentech的早期发现生物化学部门，在哈佛大学的博士后团契和McGill Univer雷竞技app推荐码sity的博士学位完成后，2006年。At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Industry's largest & most renowned event to accelerate your oligo, peptide, mRNA therapeutics to market. One of many physiological findings about lipid–protein interaction is that lipid modifications regulate some proteins generated by cancer genes, says Rami Hannoush, a chemical biologist at the. D. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 3h Report this post. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7 شهر تم التحريرRami Hannoush, Ph. Rami Hannoush, PhDPrincipal Scientist & Group Leader at Genentech. ’s Post Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. We cover Rami's new role at Versant, the founding story of. D. Rami Hannoush, Ph. 05. D. ’s Post Rami Hannoush, Ph. Rami Hannoush’s Post. edu - Homepage. Aaron H Nile & Rami N Hannoush* Wnt proteins are critical regulators of signaling networks during embryonic development and in adult tissue homeostasis. ” Prior to EpiBiologics, Dr. D. This button displays the currently selected search [email protected] Hannoush, Ph. Materials availability This study did not generate new unique reagents. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. View the profiles of professionals named "Rami D" on LinkedIn. Rami N. Currently teaching. , Partner at Apollo Health Ventures, will join the Company as Board observers. D. doi: 10. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y EditedRami Hannoush, Ph. rami@gene. , USA) "Challenges and Emerging Approaches in Peptide Drug Discovery" 9:25 am - 9:40 am: Discussion. Genentech, McGill, Harvard, Versant Ventures. D. D. Hannoush [email protected] Department of Early Discovery Biochemistry, Genentech, Inc. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6d EditedRami Hannoush, Ph. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Back. Supplementary information. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Report this post Report Report. Rami Hannoush Manage my profile. D. It is tightly controlled by a set of enzymes which catalyze the covalent attachment of fatty. THE AURON TEAM A CULTURE OF INNOVATION. D. Join to view full profile. … | 79 comments on LinkedInRami Hannoush, Ph. Mubadala Capital Ventures General Partner Sep 2021. He focuses on early. San Mateo, CA. ’s Post Rami Hannoush, Ph. Rami Hannoush 7mo Report this post 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs and protect. D. Born on September 20th, 1976 (47 years old)Rami Hannoush, Ph. Mar 22, 2023. Rami Hannoush. Adam Catherman for valuable discussions. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. teins generated by cancer genes, says Rami Hannoush, a chemical biologist at the biopharmaceutical company Genentech. . At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Many proteins have been found to be regulated through S-palmitoylation, a highly conserved process occurring in all eukaryotic organisms that involves the attachment of 16-carbon fatty acids onto cysteine residues via a reversible thioester linkage (Chamberlain and Shipston, 2015, Hannoush, 2015). References [1] J. chembiol. , Partner at Apollo Healthcare Ventures, will join the Company as Board observers. 2014. Back. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Edited Report this post Report Report. D. Its proprietary EpiTAC platform is a. Rami Hannoush, education was also an escape. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. Both structures reveal a dimeric arrangement of the CRD. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Anwesha Dey,4 Rami N. D. D. D. , discovery, toxicology, program management, business development, clinical development,. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. H. PMID: 28377511 PMCID: PMC5402412 DOI: 10. Rami N. Rami Hannoush, Ph. Its proprietary EpiTAC platform is a modular antibody-based system that enables the precise degradation of disease-driving membrane and extracellular proteins in a tissue-specific. D. Rami N. D. Electronic address: hannoush. ’s Post Rami Hannoush, Ph. I am thankful for the LPs, founders, CEOs, team members who have remained steadfast partners over the years in using advanced technology to build a better… | 13 comments on LinkedInRami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Rami Hannoush: Chemical tools to perturb and image Wnt signaling: Danica Galonic Fujimori: 3/15/12: Harmit Malik, Fred Hutchinson Cancer Center: Genetic conflicts: the usual suspects and beyond: John Gross: 4/5/12: Ian Wilson, Scripps: Broad neutralization of HIV and influenza viruses: Bob Stroud:It started with a cup of coffee and a slow burning desire to go early and long in the biotech creation business. , joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. 5 From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental. ’s Post Rami Hannoush, Ph. D. ’s Post Rami Hannoush, Ph. Rami Hannoush, Ph. Burns, Irina N. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Scroll Top. com. D. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. 4d Edited. Baig et al. The Hannoush group is focused on developing pharmacological strategies for targeting proteins and protein – protein interactions that are important in disease, with the aim of developing novel therapeutics and at the same time advancing their understanding of cellular molecular mechanisms. Read top stories published by MubadalaVentures. 10. Back. Thank you Susquehanna University and the…Surrey fellows of the future fellowships: post-doctoral fellowships opportunities leading to a tenured academic position after three years. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 5mo Report this post Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami Hannoush, Ph. Auron was founded by a world class team of physicians and scientists with proven expertise in bringing effective differentiation therapies to patients. Rami N. Back. Rami N. Stanford. D. . D. The Frizzled (FZD) 7 receptor (FZD7) is enriched in LGR5 + intestinal stem cells and plays a. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. 1038/s41589-018-0035-2 Abstract Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing. Scheme 1 S2 . Healthcare VC | Life sciences company creation 6 dComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Connected to: Abdallah A Hannoush, 36 Rita P Hannoush, 28 Rola E Hannoush, 62 Krystal L Hannouz, 44 Donna L Hanns, 61 George E Hanns, 76 Jill R Hanns, 66 Lorca L Hanns, 66 Brenda J Hannula,. ’s Post Rami Hannoush, Ph. D. , 1 DNA Way, South San Francisco, CA 94080, USA. Patrick Sexton, Monash University. When expanded it provides a list of search options that will switch the search inputs to match the. Founded in 2022 and led by CEO Dr. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 4mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. Its proprietary EpiTAC platform is a. Rami Hannoush, Ph. D. ’s Post Rami Hannoush, Ph. Rami Nabil Hannoush, Rami Hannoush, Ramin Hannoush. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush, Ph. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. D. ’s Post Rami Hannoush, Ph. Auron Therapeutics, a Newton, Mass. We are dedicated to bridging ideas from academia with the cutting edge in biotechnology and translation. Hannoush joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. Rami Hannoush (Genentech, Inc. Rami Hannoush, Ph. CSB 243: Biotechnology and Development of Therapeutics (Autumn)9 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. , South San Francisco, California, USA. Rami Hannoush is Member Board Of Directors of Neumora Therapeutics. Burns, Irina Krylova, Rami N. Genentech Inc. Its proprietary EpiTAC platform is a modular antibody-based system that enables the precise degradation of disease-driving membrane and extracellular proteins in a tissue-specific. Expand search. Marianne Mertens, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. … | 79 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. . interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. President’s Welcome. Courtesy of EpiBiologics. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. ’s Post Rami Hannoush, Ph. Congrats Cameron! Like Reply 1 Reaction. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. , as Chief Scientific Officer, Thomas Graeber, Ph. We also report a crystal structure of human FZD5 CRD bound to C16:1 cis -Δ9 unsaturated fatty acid. ’s Post Rami Hannoush, Ph. I had the pleasure to join Rob Faulkner and Soo Romanoff on a. PMID: 26080277 DOI: 10. S. Palmitate can either be added to. Rami N Hannoush, Ph. This button displays the currently selected search type. Founded in 2022 and led by CEO Dr. Lipid modification of cellular proteins plays diverse roles in the regulation of such proteins' trafficking, signaling and behavior. He is 48 year old. D. Rami Hannoush is the co-founder, interim CEO and president of EpiBiologics. 025 Abstract Fatty acylation of proteins is a versatile co-translational or post-translational modification that plays a key role in human physiology and disease. hannoush. One of many physiological findings about lipid–protein interaction is that lipid modifications regulate some proteins generated by cancer genes, says Rami Hannoush, a chemical biologist at the. D. Drug Discovery & Development Oncology Wnt and Stem. Related to: Rana Hannoush, 42. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Report this post Report Report. … | 79 comments on LinkedInRami Hannoush, Ph. D. Scalable Total Synthesis and Biological Evaluation of Haouamine A and Its Atropisomer. Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. com . Rami Hannoush, Ph. The design of clickable fatty acid probes is based on the introduction of a small chemical tag (alkyne or azide) at the ω or methyl end of the fatty acid (Figure 2). Sponsors and Exhibitors. D. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. The American Peptide Society, APS, a nonprofit scientific and educational organization founded in 1990, provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. Alanna Schepartz, The University of California, Berkeley. His current role includes leading interdisciplinary teams in lead discovery and research biology, with the overarching goal of developing therapeutics for the. D. D. D. “Jim and I have known each other for the past 15 years through Genentech collaborations. Rami Hannoush, Ph. Rami Hannoush, Ph. Lotte Simonsen, Novo Nordisk. When expanded it provides a list of search options that will switch the search inputs to match the. harvard. ’s Post Rami Hannoush, Ph. D. By Ron Leuty – Senior Reporter, San Francisco Business Times. The design of clickable fatty acid probes is based on the introduction of a small chemical tag (alkyne or azide) at the ω or methyl end of the fatty acid (Figure 2). Rami Hannoush is a venture partner operating across San Diego and the San Francisco Bay Area. PMID: 29290622 DOI: 10. D. We cover Rami's new role at Versant, the founding story of. ’s Post Rami Hannoush, Ph. He also recently joined Versant Ventures (as a venture partner) where he works on biotech company creation and life science investments. D. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics ٦ شهر الإبلاغ عن هذا المنشور. Biomarker interview with Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. D. Rami Hannoush, EpiBiologics is building a protein degradation platform that targets membrane and extracellular [email protected]. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu Ask a Lawyer. D. D. D. D. Rami Hannoush, Ph. Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Hannoush and Arenas-Ramirez, 2009; Martin and Cravatt, 2009) also showed efficient bioorthogonal labeling of fatty acyl-Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami Hannoush was treated to a caffeine-fueled review of the latest work UCSF’s Jim Wells had been doing on protein degradation — one of the hottest fields in drug development. Lee-Karlon left another Bay Area biotech company, Altos Labs, in June, according to her LinkedIn. Rami Hannoush. Rami has 3 jobs listed on their profile. Healthcare VC | Life sciences company creation 2yThe 2020 Chemistry and Biology of Peptides Gordon Research Conference will showcase the most recent, cutting edge research in advancing peptides as tools, materials, and therapeutics. D. Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. The Section of Hematology/Oncology, within the Department of Internal Medicine, Max Rady College of Medicine, in affiliation with CancerCare Manitoba (CCMB) as the Department. D. D. Operating Status Active. Human OS cell lines (MNNG/HOS, MG-63, and U2-OS) were treated with increasing concentrations of dynasore or cisplatin, and then the cell. We cover his grad school/post-doc training in chemical biology, 15+ years as a group leader Genentech and. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. A fascinating approach to degrade membrane proteins/receptors. 5W96, 5WBS. This button displays the currently selected search type. Clickable fatty acids coupled with in situ proximity ligation allow visualization of Wnt as it trafficks through the secretory pathway, defining roles for palmitoylation and glycosylation in. Run Background Search. Discover Digital Health profiles, team, funding and valuation with HealthTech Alpha. She joined Altos at its initiation in 2021 and wasPostdoctoral Research Fellow, Chemical Biology and Biochemistry, Rami Hannoush lab, Genentech Research chez Roche in South San Francisco. Fairbrother, ,* and Christian N. EpiBiologics Co-Founder. D. Connect Show more profiles Show fewer profiles Explore collaborative articles We’re. ’s Post Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. hannoush. Healthcare VC | Life sciences company creation 6 TageThank you Ayman, Alaa, and Rami for your trust and support! Could not have asked for better partners. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. This paper describes a multi-parametric method for quantitative analysis of cellular beta-catenin protein levels in a rapid and high-throughput manner. Hannoush include Harvard University & Scripps Research Institute. Noah Z. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. . English. com. Ethics declarations. Over the weekend, I received the Outstanding Recent Alumnus Award alongside some incredibly accomplished individuals. ’s Post Rami Hannoush, Ph. Healthcare VC | Life sciences company creation 1y 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs. D. D. Schneider, National Cancer Institute – Center for Cancer Research. Manage my profile. ” Prior to EpiBiologics, Dr. He brings a unique blend of investment experience and deep drug discovery expertise to our company creation efforts. D. Mr. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. ’s Post Rami Hannoush, Ph. Rami N Hannoush is part of Stanford Profiles, official site for faculty, postdocs, students and staff information (Expertise, Bio, Research, Publications, and more). Mubadala Capital Ventures General Partner Sep 2021. Hannoush has filed for patents to protect the following inventions. Last Funding Type Series A. Antibody Engineering & Therapeutics is the largest forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation bindersRami Hannoush, Ph. Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami. Rami Hannoush, PhD. D.